These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16406697)

  • 41. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
    Gilliam FG; Veloso F; Bomhof MA; Gazda SK; Biton V; Ter Bruggen JP; Neto W; Bailey C; Pledger G; Wu SC
    Neurology; 2003 Jan; 60(2):196-202. PubMed ID: 12552030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
    Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy.
    Boon P; Chauvel P; Pohlmann-Eden B; Otoul C; Wroe S
    Epilepsy Res; 2002 Jan; 48(1-2):77-89. PubMed ID: 11823112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of the initial efficacy of levetiracetam in patients with refractory epilepsy.
    Lee GH; Kim BM; Kang JK; Lee SA
    Seizure; 2013 Apr; 22(3):185-8. PubMed ID: 23280273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of levetiracetam in refractory childhood epilepsy syndromes.
    Lagae L; Buyse G; Deconinck A; Ceulemans B
    Eur J Paediatr Neurol; 2003; 7(3):123-8. PubMed ID: 12788038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
    Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topiramate in add-on therapy: results from an open-label, observational study.
    Krakow K; Lengler U; Rettig K; Schreiner A; Schauble B;
    Seizure; 2007 Oct; 16(7):593-600. PubMed ID: 17543544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.
    Cereghino JJ; Biton V; Abou-Khalil B; Dreifuss F; Gauer LJ; Leppik I
    Neurology; 2000 Jul; 55(2):236-42. PubMed ID: 10908898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
    Dooley M; Plosker GL
    Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group.
    Shorvon SD; Löwenthal A; Janz D; Bielen E; Loiseau P
    Epilepsia; 2000 Sep; 41(9):1179-86. PubMed ID: 10999557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures.
    Inoue Y; Yagi K; Ikeda A; Sasagawa M; Ishida S; Suzuki A; Yoshida K;
    Psychiatry Clin Neurosci; 2015 Oct; 69(10):640-8. PubMed ID: 25854635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
    Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
    Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.
    Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S;
    Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial.
    Lagae L; Buyse G; Ceulemans B
    Seizure; 2005 Jan; 14(1):66-71. PubMed ID: 15642504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy.
    Vajda FJ; O'Brien T; Lander C; Graham J; Eadie M
    Epilepsia; 2014 Aug; 55(8):1229-34. PubMed ID: 24995555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low-dose topiramate in adults with treatment-resistant partial-onset seizures.
    Guberman A; Neto W; Gassmann-Mayer C;
    Acta Neurol Scand; 2002 Oct; 106(4):183-9. PubMed ID: 12225311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Efficacy and tolerability of topiramate, lamotrigine, and levetiracetam in children with refractory epilepsy].
    Kato T; Nakata M; Ide M; Saito K; Yoshida T; Awaya T; Heike T
    No To Hattatsu; 2015 Sep; 47(5):354-9. PubMed ID: 26502652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.
    Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R
    Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.